IndianaSyringe exchange program.
What it does
Prohibits a qualified entity that operates a syringe exchange program (program) from establishing or operating a fixed site for the distribution or exchange of a syringe or needle within 1,000 feet of specified facilities. Creates an exception. Allows the Indiana department of health to deny, suspend, or revoke a qualified entity's annual registration for a violation.
More detail
Amends the duties of a qualified entity that operates a program. Establishes requirements for program participation. Prohibits a qualified entity that operates a program from providing chemical reagents or precursors. Requires the state health commissioner to investigate any complaint regarding a qualified entity's noncompliance with the qualified entity's duties concerning the operation of a program. Permits the state health commissioner to suspend or terminate the approval of a qualified entity for noncompliance. Extends the expiration of the program to July 1, 2031.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Mar 10Public Law 144Latest
- Mar 10Bill Became Law on 8th Day Without SignatureBecame Law
- Feb 27Signed by the President Pro TemporeMajor
- Feb 27Signed by the SpeakerMajor
- Feb 27Signed by the President of the SenateMajor
- Feb 25Senate concurred with House amendments; Roll Call 273: yeas 38, nays 10
- Vote recorded SB 91 - Crider. Result: pass.Upper
- Feb 19Returned to the Senate with amendmentsMinor
- Feb 19Motion to concur filedMinor
- Feb 18Third reading: passed; Roll Call 271: yeas 70, nays 22Passed House
- Vote recorded SB 91 - Clere - 3rd Reading. Result: pass.Lower
- Feb 17Amendment #11 (Mayfield) prevailed; voice voteMajor
- Feb 17Second reading: amended, ordered engrossedMinor
- Feb 17Representatives Zimmerman, Garcia Wilburn added as cosponsors
- Feb 17Amendment #14 (Clere) prevailed; voice voteMajor
- Feb 17Amendment #12 (Ireland) prevailed; voice voteMajor
- Feb 10Committee report: amend do pass, adoptedMinor
- Jan 29First reading: referred to Committee on Public HealthMinor
- Jan 28Referred to the HouseMinor
- Jan 28Representative Goss-Reaves removed as cosponsor
- Jan 27Cosponsors: Representatives Lawson, Goss-Reaves
- Vote recorded SB 91 - Crider - 3rd Reading. Result: pass.Upper
- Jan 27Third reading: passed; Roll Call 93: yeas 33, nays 13Passed Senate
- Jan 27House sponsor: Representative Clere
- Jan 27Senator Pol added as coauthor
- Jan 26Second reading: amended, ordered engrossedMinor
- Jan 26Amendment #2 (Crider) prevailed; voice voteMajor
- Jan 20Senator Randolph added as coauthor
- Jan 13Senators Bohacek, Jackson L added as coauthors
- Jan 12Senator Walker K added as coauthor
- Jan 8Senator Charbonneau added as second author
- Jan 8Committee report: do pass, adoptedMinor
- Jan 8Senator Clark added as third author
- Jan 8Senator Yoder added as coauthor
- 2025
- Dec 9Authored by Senator Crider
- Dec 9First reading: referred to Committee on Health and Provider ServicesIntroduced